← Browse by Condition
Medical Condition

refractory acute lymphoid leukemia

Total Trials
1
Recruiting Now
1
Trial Phases
Various
NCT06389305
Recruiting

CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction

Enrollment
213 pts
Location
China
Sponsor
Beijing GoBroad Hospital
View Trial →